alexa Drug Repurposing Screen For Rapid Identification Of Therapeutics For Zika Virus Infection
ISSN: 2157-7412

Journal of Genetic Syndromes & Gene Therapy
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

2nd World Congress on Rare Diseases and Orphan Drugs
June 29-30, 2017 London, UK

Wei Zheng
National Institutes of Health, USA
ScientificTracks Abstracts: J Genet Syndr Gene Ther
DOI: 10.4172/2157-7412-C1-012
Abstract
Zika virus infection with complications of microcephaly and other complications has emerged as a health threat in many countries where the infection has been reported in over 60 countries. Vaccines and therapeutics are currently unavailable for the Zika virus infection. We have developed several compound screening assays and carried out the drug repurposing screens to identify potential therapeutics for the Zika virus infection. The newest results on drug repurposing screens and Zika virus drug development will be presented in this talk.
Biography

Wei Zheng received his PhD in Pharmacology from the State University of New York at Buffalo. He had worked for 12 years in pharmaceutical companies (Berlex, Amgen, and Merck) for drug discovery and development. Since 2005, he has worked at National Institutes of Health for development of therapeutics for rare and neglected diseases. He has identified several drugs from drug repurposing screens and advanced two of them to clinical trials. Currently, he is working on the therapeutics development for lysosomal storage diseases, drug resistant cancer and infectious diseases.

Email: [email protected]

image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords